print email comment close FDA Asks Attention-Deficit Hyperactivity Disorder (ADHD) Drug Manufacturers to Develop Patient Medication Guide URL: http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm107918.htm Description: Documents related to the Federal Drug Administration (FDA) directive in 2006 to "manufacturers of all drug products approved for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) to develop patient Medication Guides to alert patients to possible cardiovascular risks and risks of adverse psychiatric symptoms associated with the medicines, and to advise them of precautions that can be taken." Provides medication guides and labels for specific drugs, press release, and FDA committee transcripts. Publisher: U.S. Federal Drug Administration (FDA), Center for Drug Evaluation and Research Extra Keywords Adderall Ritalin LII Database Information: Record 24363 created by Jennifer English on 08/24/2007 Last modification on 06/04/2009 Published: 08/29/2007   Funding agency: California State Library LII Item ID: http://lii.org/cs/lii/view/item/24363